Trials / Conditions / Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)
5 registered clinical trials studyying Hemophagocytic Lymphohistiocytosis (HLH) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in NCT07525466 | Beijing Tongren Hospital | Phase 1 / Phase 2 |
| Not Yet Recruiting | Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis NCT06951971 | The First Affiliated Hospital of Soochow University | Phase 2 / Phase 3 |
| Completed | Treatment of Familiar Lymphohistiocytosis NCT02472054 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Completed | T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts NCT00368355 | Baylor College of Medicine | Phase 2 |
| Completed | Investigation of Ferritin in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis NCT02854943 | Gunnar Lachmann | — |